National Edu News: Secretary Higher Education urges students to emerge as job creators | National Edu News: PM addresses the 18th Convocation of Tezpur University, Assam | Leadership Instincts: Experts highlight the need for strengthening centre-state cooperation | Policy Indications: India’s global position rises both in innovations & publications | Education Information: Written Result of Indian Economic Service/Indian Statistical Service Examination | National Edu News: AstroSat’s Ultraviolet Imaging Telescope spots rare ultraviolet-bright stars | Parent Interventions: Randomized trials could help to return children safely to schools | Parent Interventions: How fellow students improve your own grades | Parent Interventions: School-made lunch 'better' for children | Teacher Insights: Second Anniversary of India Science, Nation’s OTT Channel | Leadership Instincts: Participation of MGIEP in the Implementation of NEP 2020 | Teacher Insights: World of Puzzling Patterns | Education Information: HKUST Collaborates with Hang Lung to Foster Young Mathematics Talent | Leadership Instincts: Global Environment Outlook 6 Chinese version launched | Leadership Instincts: Peking University academics visits Beijing Representative Office of World Bank |

November 22, 2019 Friday 11:03:56 AM IST

New system to control blood glucose levels

A clinical trial evaluating a new artificial pancreas system - which automatically monitors and regulates blood glucose levels - has found that the new system is more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes. The trial, based partly at the University of Virginia Center for Diabetes Technology, was published in the New England Journal of Medicine.

The artificial pancreas, also known as closed-loop control, is an ‘all-in-one’ diabetes management system that tracks blood glucose levels using a continuous glucose monitor (CGM) and automatically delivers the hormone insulin when needed using an insulin pump. The system replaces reliance on testing by fingerstick or CGM with separate delivery of insulin by multiple daily injections or a pump.

The system improved blood glucose control throughout the day and overnight. Overnight control has been a challenge since blood glucose can drop to dangerously low levels when a person is asleep.